Case Report on Phenytoin-Induced Toxic Epidermal Necrolysis
Abstract
Toxic epidermal necrolysis is a cutaneous drug reaction which is a severe adverse effect that predominantly involves the skin and mucous membrane. Phenytoin is an anti-epileptic medication that belongs to the hydantoin class. Here we are going to present a case of 50-year-old male patient with phenytoin induced toxic epidermal necrolysis. The outcome of this study was to determine the severity of the adverse reaction and its management to improve the patient condition.
Keywords: Toxic epidermal necrolysis, phenytoin, erythromatous, adverse drug reaction, body surface area.
Keywords:
oxic epidermal necrolysis, phenytoin, erythromatous, adverse drug reaction, body surface areaDOI
https://doi.org/10.22270/jddt.v12i4-S.5595References
Mudigubba MK, Mahantheswarapa Y, Moola K, Bathula G, Rajashekarachar Y, Raghunathnaidu BD. Toxic epidermal necrolysis induced by Phenytoin: A case study. Indian Journal of Pharmacy Practice. 2014; 7(2):37–9.
Tripathi K. Essentials of Medical Pharmacology. Jaypee Brothers, Medical Publishers Pvt. Limited; 2008
Zaki SA. Adverse drug reaction and causality assessment scales [Internet]. Lung India: official organ of Indian Chest Society. Medknow Publications; 2011 [cited 2022Jul6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109846/
Christa Prins MD. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins [Internet]. Archives of Dermatology. JAMA Network; 2003 [cited 2022Jul6]. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/479146#:~:text=Conclusions%20Early%20infusion%20of%20high,per%20day%20for%203%20days).
Published
Abstract Display: 429 
PDF Downloads: 618 PDF Downloads: 43 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.